FDA Stapler Safety Scrutiny Puts Intuitive Surgical Q1 2026 In Focus
✦ NabkaNews BriefAuto-summarized from multiple outlets · verify with the source
The FDA is scrutinizing the safety of staplers, which may impact Intuitive Surgical's first quarter 2026 performance. Intuitive Surgical has issued a recall, classified as a Class I recall by the FDA, and this has raised questions about the reliability of revenue from its da Vinci product. The recall and subsequent selling by institutions may have implications for the company's shareholders.